Our Work

Over the years, we have conducted many successful research projects throughout the world.  Please read about our past projects, our current work, and our vision for the future.

Chinese Multi-center Screening Trial that will take place in five sites in China, which are 1) Beijing, 2) Shanghai, 3) Shijiazhuang, Hebei Province, 4) Wuhan, Hubei Province, and 5) Wushen County, Erdose, Inner Mongolia. The primary objective of the project will be to evaluate the Cobas 4800 HPV Assay, the …

Learn More: CHIMUST »

CHICAPS (Chinese Cervical Cancer Prevention Study) Over the past several years the focus of cervical cancer screening programs designed for mass screening and able to reach the underserved, have ranged from complex infrastructure demanding cytology (Pap) based efforts, to very low tech unaided visual inspection programs (using 5% acetic acid). …

Learn More: CHICAPS »

With great progress in HPV assay development over the past 5-7 years, and especially PCR based assays, BGI Shenzhen (the world’s largest genomic sequencing facility) asked the question if sequencing technology can move the science and the POI screening paradigm even further. With the new bench-top next generation sequencing instruments …

Learn More: SEQHPV »

The Peru Cervical Cancer Prevention Study PERCAPS was a 2 Phase pilot project funded through the Merck Investigator Initiated Studies Program. It represented the first project for POI in our new community based screening initiative. After years of technology based studies, we believed the important elements of screening technologies were …

Learn More: PERCAPS »